Overview

A Drug-Drug Interaction Study of Losartan and PA21

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Losartan potassium is affected by PA21.
Phase:
Phase 1
Details
Lead Sponsor:
Vifor Inc.
Vifor Pharma
Treatments:
Losartan